Skip to main content

PARENTERALS I : Basics, route of administration, solvents used

Basics of parenteral dosage forms

Parenteral route: para- other, -enteral- intestine.

Parenteral dosage form: It can be defined as a sterile drug product, which is presented in the form of solution, suspension, emulsion or reconstituted lyophilised powder, suitable for administration by injection.

Routes of administration of parenterals:
1. Intravenous
2. Subcutaneous
3. Intramuscular
4. Intradermal
5. Intraspinal
6. Intrathecal
7. Intraarterial
8. Intraepidural
9. Intra-vitreous



  • Maximum volume for single dose container: upto 1000 ml.
  • Maximum volume for multi-dose container: up to 30 ml 
  • Maximum volume for intradermal administration: 0.2 ml
  • Maximum volume for subcutaneous administration: 1 ml
  • Maximum volume for intramuscular administration: 2 ml/ 5 ml (for gluteal muscles).
  • Maximum volume for intraarterial, intracardiac and intraspinal administration: 10 ml (without bactericide).
  • Maximum volume for intravenous administration: 1000 ml ( 1 Liter).
  • Maximum volume for intracorneal, sub-conjunctival and intravitreous administration: not exceeding 1 ml.

  1. Volume not more than 20 ml should be administered by syringe.
  2. Parenteral suspensions should not be given by intravenous route (blockage of small capillaries) and subcutaneous route (painful and irritating).
  3. Mostly the vehicle for intravenous and intraspinal administration is aqueous in order to avoid damage to the brain capillaries.
  4. In case of  intramuscular administration preparations can be aqueous or oil based.

VEHICLE USED FOR PARENTERAL PREPARATIONS
Mostly water is used in the parenteral formulations.
Depending on the stages at which water is used, it is divided into three categories:
  1. Water for Injection (WFI): WFI is prepared by distillation or 2 stage reverse osmosis. It is used as a solvent for preparation of most of the injections. It should not contain more than 0.25 USP endotoxin units.
  2. Sterile Water of Injection: Sterile WFI is prepared by sterilization of WFI. Limits for total solid content are slightly higher for Sterile WFI than WFI. This is the case because, WFI is packaged and then containers are sterilized (possibility of leaching of container material into water). Sterile water for injection is used only for dilution and reconstitution purposes with addition of isotonicity agent. It is supplied only as a single dose container.
  3. Bacteriostatic Water for Injection: It is same as that of sterile water for injection and serves the same purpose. It is packaged as a single or multiple-dose container of volume not more than 30 ml. It is packaged along with bacteriostatic agents.

CO-SOLVENTS
  • Co-solvents are the water miscible materials (liquids) used for solubilization of drug in the water.
  • Examples- glycerin, ethyl alcohol, polyethylene glycol (PEG), propylene glycol, dimethyl acetamide, etc.
NON-AQUEOUS VEHICLES

  • In oil- based and emulsion preparations certain fixed oils are used.
  • Paraffin oil is never used in parenteral formulations.
  • Sesame oil, cotton seed oil, isopropyl myristate, ethyl oleate.
  • Sesame oil is having antioxidant properties.
  • Commonly used non-aqueous solvents other than water are propylene glycol and polyethylene glycol.

Comments

Popular posts from this blog

TABLETS

    Short notes on tablets I In this first article on tablets I am going to provide some important points regarding tablet formulation.   ü   I : Advantages, disadvantages, tablet defects and the excipients used in the formulation of tablets ü   II : Evaluationparameters and types & classes of tablets . Second part of this topic will be provided in the next post. So, for short notes on second point please refer the next post. Let’s start with the first point in this topic. ADVANTAGES OF TABLETS Oral route of administration is the most preferred route for the administration of drugs for their systemic effects. Tablets are mostly preferred for this due to following advantages: ·          Unit dosage forms ·          Greatest dose precision ·          Least content variability ·          Lowest cost ·          The lightest and the most compact oral dosage forms ·          Easy transportation as compared to liquids ·          Product identification is easy

Linctuses: Monophasic Liquid Dosage Form

  LINCTUSES What is a Linctus? Linctuses are sweet, viscous liquid oral preparations containing medicinal substances which have demulscent, expectorant or sedative properties. These contain high proportions of syrup and glycerin which exert demulscent effect on the mucous membrane of throat. In order to obtain prolonged local action, linctuses should be administered slowly in undiluted form. Formulation of Linctus  1. Vehicle : Syrups are mostly used as vehicles in the linctuses. Tolu syrup is preferred in cough preparations due to its aromatic odor and flavour. Glycerol syrup and invert syrup are also used as vehicles. Linctus preparation for diabetic patients contain sorbitol syrup (vehicle). Medicament is first dissolved in little amount of water and then added into vehicle. Syrups are viscous and contain less amount of water, this limits (affects) the dissolution of medicament in syrup. 2. Additives: Colouring agents : Amaranth, Erythrosin, Tartrazine. Flavouring agents : Lemon syr

UV-Visible spectroscopy: Basics

Ultraviolet Spectroscopy In this anaytical technique, ultraviolet radiations are used. Wavelength ranges of radiations: Visible light : 400 - 800 nm Near UV radiations : 200 - 400 nm Far/ Vacuum UV : below 200 nm Generally, we carry out UV analysis in near UV region of radiations. PRINCIPLE : Electronic transitions When a molecule absorbs UV radiations, the electronic excitation occur where electrons go from lower to higher energy state.  Electronic excitation causes the electron to go from electron bonding orbital to antibonding orbital. After some time electron returns to its original state (stable). While returning to its stable form (into bonding orbital) it releases excess energy. That energy is measured by the detector to access the wavelength (λmax) /absorption pattern. TRANSITIONS: σ → σ* (126-135 nm) n → σ* (180-200 nm) π → π* n → π* ALLOWED TRANSITION:  π → π* FORBIDDEN TRANSITIONS:    n → π* ENERGY OF VARIOUS TRANSITIONS: σ